{"id":"W4206730501","doi":"10.1200/jco.2022.40.4_suppl.427","title":"Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Interim analysis; Tolerability; Interim; Oncology; Cohort; Population; Progression-free survival; Tumor progression; Clinical trial; Gastroenterology; Progressive disease; Phases of clinical research; Surgery; Adverse effect; Cancer; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002062414,0.0001450488,0.001132795,0.0001572045,0.0001253806,0.00001006573,0.0003107913,0.00006687825,0.0001397917],"category_scores_gemma":[0.005672993,0.0000806821,0.0002445156,0.0004360797,0.0002083656,0.00007935012,0.0001338023,0.001009399,0.000002630569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001398899,"about_ca_system_score_gemma":0.00100066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002845719,"about_ca_topic_score_gemma":0.0005069153,"domain_scores_codex":[0.9955514,0.0008248182,0.002681459,0.0002512402,0.0005101656,0.0001809362],"domain_scores_gemma":[0.9903734,0.006896756,0.001863168,0.0003680204,0.0003724793,0.0001261615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0430649,0.01587606,0.8998423,0.000007873931,0.0007521029,0.0003021735,0.005720775,0.00003863385,0.00001251763,0.000005992628,0.002704507,0.03167213],"study_design_scores_gemma":[0.05669645,0.02782306,0.9063939,0.00006486304,0.0005833384,0.00003188221,0.004908807,0.00003235658,0.000006650825,0.00003002227,0.003351244,0.00007741238],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935652,0.0003239549,0.00003314387,0.004486341,0.0004922867,0.0008102514,0.00008652295,0.000006575538,0.0001957457],"genre_scores_gemma":[0.9981554,0.00004166066,0.000544903,0.0008308777,0.0002908121,0.00003928817,0.0000507388,0.0000161974,0.00003013286],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03159472,"threshold_uncertainty_score":0.6791512,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1625817100748356,"score_gpt":0.4649976609331365,"score_spread":0.302415950858301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}